-
EAU 2025丨Dr. Siamak Daneshmand Shares the Potential of Oncolytic Virus Therapy for NMIBC Patients
For patients with non-muscle-invasive bladder cancer (NMIBC) who do not respond to Bacillus Calmette-Guérin (BCG) therapy, clinicians and researchers are actively exploring novel treatment strategies. Among these, oncolytic virus therapy has emerged as a promising approach. At the 40th Annual EAU Congress, Dr. Siamak Daneshmand from the University of Southern California (USC) presented two key…
-
EAU 2025 | Non-Invasive Evaluation of Tumor Heterogeneity in BCR: Professor Xuefeng Qiu Shares Advancements and Clinical Experience with PSMA-PET/CT at Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School，Nanjing University
In recent years, prostate-specific membrane antigen (PSMA) molecular imaging technology has demonstrated significant value in the diagnosis and treatment of prostate cancer. It has improved the accuracy of clinical staging, supported multimodal treatment decision-making, and facilitated the development of precision medicine through novel radioligand therapies. At the recent EAU Congress, UroStream invited Professor Xuefeng Qiu…
-
Professor Michael Gnant, SGBCC President, Visits The Second Hospital of Dalian Medical University for Academic Exchange on Cutting-Edge Breast Cancer Diagnosis and Treatment
The St. Gallen International Breast Cancer Conference (SGBCC) is one of the most authoritative and influential global events in the field of breast cancer, dedicated to advancing standardized diagnosis and treatment for early-stage breast cancer. To integrate international frontier concepts with domestic clinical practice and align China’s breast cancer care with global standards—ultimately delivering superior…
-
Advancing Prostate Cancer Diagnosis: Professor Declan Murphy Presents Results from the TRANSLATE Trial Comparing TP vs TRUS Biopsy
At the highly anticipated Game Changer Session at EAU25, Professor Declan Murphy (Peter MacCallum Cancer Centre, Melbourne) delivered an impactful presentation on the results of the TRANSLATE trial, a multicentre,…
-
EBMT 2025 | Post-Transplant Outcomes in AML with Haploidentical Donors
At the 51st Annual Meeting of EBMT, Dr. Eduardo Rodríguez-Arbolí presented important long-term data from an ALWP-EBMT study focusing on patients with acute myeloid leukemia (AML) who underwent haploidentical HSCT…
-
EAU25 | Final Survival Results from SPCG-13 Trial: Surveillance vs. Docetaxel After Radiotherapy in High-Risk Prostate Cancer
In a Game Changer Session at EAU25, Prof. Kellokumpu-Lehtinen Pirkko-Liisa presented the 10-year follow-up from the Scandinavian Prostate Cancer Study Group-13 trial (SPCG-13), exploring adjuvant docetaxel versus surveillance following curative…
-
Can a short video ease the mind of a worried parent?
At EAU25, Dr. Mehmet Cetin from Marmara University School of Medicine (Istanbul) presented a prospective randomized controlled study evaluating the impact of video-based informed consent on the anxiety levels of…
-
APASL China Voice | Dr. Rong Fan: The Application of Cell-Free DNA Testing in Early Hepatocellular Carcinoma Surveillance
In recent years, cell-free DNA (cfDNA)—a novel biomarker—has drawn increasing attention for its potential in early prediction and precise diagnosis of HCC. On March 29, during a parallel session at…
Connecting Medical Expertise through Media